Head and Neck Neoplasms: all 2,403 studies
Page 20 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.
- Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck CancerCompletedNCT01359267Early Phase 1
- Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyCompletedNCT01358097
- Prevention of Trismus During Radiotherapy and Quality of Life in Head and Neck Cancer PatientsStatus unknownNCT01354548Not applicable
- The Effect of Prophylactic Swallowing Exercises on Head and Neck Cancer PatientsCompletedNCT01349309Not applicable
- PET With [18F]HX4 in Head and Neck CancerCompletedNCT01347281Not applicable
- Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.CompletedNCT01341535Phase 2
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNCT01334177Phase 1
- Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck CancerTerminatedNCT01333852Phase 2
- Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by SurgeryCompletedNCT01333085Phase 1/2
- The ARTERY FIRST Approach for Resection of Pancreatic Head CancerStatus unknownNCT01332773Phase 3
- Resistance Training and Physical Functioning in Head and Neck Cancer PatientsCompletedNCT01332682Phase 1
- Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
- Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck CancerWithdrawnNCT01326468Not applicable
- Economisation of Whipple Resection Using an Ultrasonic Dissection DeviceCompletedNCT01321450
- Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?CompletedNCT01317589Phase 4
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
- A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck CancerCompletedNCT01314755Not applicable
- Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerTerminatedNCT01313390Phase 1/2
- Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent PanitumumabWithdrawnNCT01312493Phase 2
- Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and NeckStatus unknownNCT01301248Phase 2
- Prospective Study of Head and Neck Cancer Radiation Treatment With or Without AmifostineWithdrawnNCT01288625Phase 4
- Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective NeckCompletedNCT01287390Phase 2
- Controlled Trial Of Acupuncture To Prevent Radiation-Induced XerostomiaActive, not recruitingNCT01266044Phase 3
- Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck CancerCompletedNCT01264328Phase 2
- Pilot Study for Locally Advanced Head and Neck CancerWithdrawnNCT01262859Phase 2
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and RadiationStatus unknownNCT01260480Phase 2
- Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck CancerCompletedNCT01255800Phase 1
- Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerStatus unknownNCT01254591Not applicable
- Evaluation of the Role of Prostaglandins in Radiation-induced MucositisCompletedNCT01252498
- Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck CancerStatus unknownNCT01247246Phase 2
- Reirradiation and Erbitux in the HNSCCCompletedNCT01237483Phase 2
- Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck CancerCompletedNCT01235052Not applicable
- In-Room PET in Proton Radiation TherapyCompletedNCT01228448Not applicable
- Comprehensive Assessment of Head and Neck Cancer SurvivorsCompletedNCT01222481
- Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By SurgeryActive, not recruitingNCT01220583Phase 2
- Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck CancerTerminatedNCT01216020Phase 2
- Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation TherapyStatus unknownNCT01210872
- A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck CancerCompletedNCT01208883Phase 1
- Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation TherapyCompletedNCT01194635
- Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without CetuximabCompletedNCT01192750
- Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck CancerCompletedNCT01187472
- The Fibrosis-Lymphedema Continuum in Head and Neck CancerCompletedNCT01187173
- Lapatinib and Cetuximab in Patients With Solid TumorsCompletedNCT01184482Phase 1
- Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of TreatmentWithdrawnNCT01184027
- Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive TractWithdrawnNCT01175499Not applicable
- Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck CancerCompletedNCT01173172Phase 1/2
- Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer PatientsCompletedNCT01172470Phase 2
- Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck CancersCompletedNCT01163487Phase 1
- Curcumin Biomarker Trial in Head and Neck CancerCompletedNCT01160302Early Phase 1
- L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerCompletedNCT01155609Not applicable
- Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT01154920Phase 2
- Study of Chemo-Immunotherapy in Head and Neck Cancer PatientsStatus unknownNCT01149902Phase 1
- Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck CancerCompletedNCT01149642Not applicable
- Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsTerminatedNCT01137162
- Effectiveness in Head and Neck Cancer Detection Using Positron Emission Tomography (PET) Insert DeviceWithdrawnNCT01133262
- Goal Directed Fluid Therapy in Free Flap Reconstructive SurgeryCompletedNCT01129037Not applicable
- Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck CancerTerminatedNCT01126216Phase 3
- Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck CancerCompletedNCT01126008Phase 2
- Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.Status unknownNCT01124409Phase 3
- Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid CancerStatus unknownNCT01118065Phase 2
- Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & NeckCompletedNCT01116336Phase 1
- FNA Tumor Sampling for CD137 Modulation: A Pilot StudyTerminatedNCT01114256
- A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck CancerTerminatedNCT01111942Early Phase 1
- Normalcy of Food Intake in Head and Neck Cancer PatientsCompletedNCT01110980Not applicable
- Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With RadiotherapyCompletedNCT01102621
- Smoking Cessation Treatment for Head & Neck Cancer PatientsActive, not recruitingNCT01098955Early Phase 1
- Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck CancerCompletedNCT01098669
- Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorTerminatedNCT01096381
- Electromyographic Activity of Masseter Muscle During Deglutition in Total Laryngectomized SubjectsCompletedNCT01095289
- PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With InflammationsCompletedNCT01089998Phase 1
- Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck RegionCompletedNCT01083875Phase 2
- Head and Neck Cancer Registry (LORHAN)CompletedNCT01080313
- Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in KoreaCompletedNCT01075828
- RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck CancerTerminatedNCT01058408Phase 1
- Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck CancerTerminatedNCT01053546Not applicable
- Chlorhexidine Gel Therapy for Cariogenic Oral MicrofloraCompletedNCT01036412Phase 1
- The Physiological Response to Routine Head and Neck Cancer SurgeryCompletedNCT01032096
- Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging SystemCompletedNCT01030497
- DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer PatientsCompletedNCT01025518Not applicable
- Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck CancerCompletedNCT01024101Phase 2
- Cetuximab in Combination With Chemotherapy for Patients With Head and Neck CancerWithdrawnNCT01020864Phase 2
- DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT01017224
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial LesionsCompletedNCT01017185Phase 1
- Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871CompletedNCT01015963
- Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck CancerTerminatedNCT01011842Not applicable
- Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPCStatus unknownNCT00997906Phase 2/3
- Acute and Longlasting Side Effects Caused by Radiotherapy in the Head and Neck AreaCompletedNCT00995319
- Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration TrialCompletedNCT00995293Phase 3
- Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) ResponseTerminatedNCT00994201
- Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous CancerCompletedNCT00993512Phase 1
- MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck CancerCompletedNCT00984074
- FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N CancerStatus unknownNCT00983697Not applicable
- Treatment of Advanced Head and Neck CancerTerminatedNCT00982696Phase 2
- Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck CancerStatus unknownNCT00982436Phase 1/2
- Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck TumorsCompletedNCT00978081Phase 1
- Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck CancerCompletedNCT00973947Not applicable
- Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1CompletedNCT00968656Phase 1
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
- Quality of Life in Patients Treated for Head and Neck CancerCompletedNCT00963586
- Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerCompletedNCT00963326